455 related articles for article (PubMed ID: 32239241)
1. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
[TBL] [Abstract][Full Text] [Related]
2. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
3. Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas.
Kong Z; Jiang C; Zhang Y; Liu S; Liu D; Liu Z; Chen W; Liu P; Yang T; Lyu Y; Zhao D; You H; Wang Y; Ma W; Feng F
Front Neurol; 2020; 11():551771. PubMed ID: 33192984
[No Abstract] [Full Text] [Related]
4. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.
Lu J; Li X; Li H
Clin Radiol; 2022 Aug; 77(8):e560-e567. PubMed ID: 35595562
[TBL] [Abstract][Full Text] [Related]
5. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
[TBL] [Abstract][Full Text] [Related]
7. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
[TBL] [Abstract][Full Text] [Related]
8. Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas.
Park YW; Ahn SS; Park CJ; Han K; Kim EH; Kang SG; Chang JH; Kim SH; Lee SK
Eur Radiol; 2020 Dec; 30(12):6475-6484. PubMed ID: 32785770
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in Midline Gliomas.
Kandemirli SG; Kocak B; Naganawa S; Ozturk K; Yip SSF; Chopra S; Rivetti L; Aldine AS; Jones K; Cayci Z; Moritani T; Sato TS
World Neurosurg; 2021 Jul; 151():e78-e85. PubMed ID: 33819703
[TBL] [Abstract][Full Text] [Related]
10. Multimodal MRI-based radiomic nomogram for predicting telomerase reverse transcriptase promoter mutation in IDH-wildtype histological lower-grade gliomas.
Huo X; Wang Y; Ma S; Zhu S; Wang K; Ji Q; Chen F; Wang L; Wu Z; Li W
Medicine (Baltimore); 2023 Dec; 102(51):e36581. PubMed ID: 38134061
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
[TBL] [Abstract][Full Text] [Related]
12. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
[TBL] [Abstract][Full Text] [Related]
13. Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status.
Park YW; Kim S; Park CJ; Ahn SS; Han K; Kang SG; Chang JH; Kim SH; Lee SK
Eur Radiol; 2022 Dec; 32(12):8089-8098. PubMed ID: 35763095
[TBL] [Abstract][Full Text] [Related]
14. MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.
Li Y; Qian Z; Xu K; Wang K; Fan X; Li S; Jiang T; Liu X; Wang Y
Neuroimage Clin; 2018; 17():306-311. PubMed ID: 29527478
[TBL] [Abstract][Full Text] [Related]
15. Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis.
Nakamoto T; Takahashi W; Haga A; Takahashi S; Kiryu S; Nawa K; Ohta T; Ozaki S; Nozawa Y; Tanaka S; Mukasa A; Nakagawa K
Sci Rep; 2019 Dec; 9(1):19411. PubMed ID: 31857632
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI.
Tian H; Wu H; Wu G; Xu G
Biomed Res Int; 2020; 2020():3872314. PubMed ID: 32509858
[TBL] [Abstract][Full Text] [Related]
18. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study.
Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W
J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909
[TBL] [Abstract][Full Text] [Related]
20. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.
Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK
Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
